Peri-procedural anticoagulation in patients with end-stage kidney disease undergoing atrial fibrillation ablation: results from the multicentre end-stage kidney disease–atrial fibrillation ablation registry

AIMS: The optimal anticoagulation regimen in patients with end-stage kidney disease (ESKD) undergoing atrial fibrillation (AF) catheter ablation is unknown. We sought to describe the real-world practice of peri-procedural anticoagulation management in patients with ESKD undergoing AF ablation. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Tasuku, Miyazaki, Shinsuke, Tanaka, Yasuaki, Kono, Toshikazu, Nakata, Tadanori, Mizukami, Akira, Aoyama, Daisetsu, Arai, Hirofumi, Taomoto, Yuta, Horie, Tomoki, Hojo, Rintaro, Kawamoto, Shiho, Yabe, Kento, Akiyoshi, Kikou, Kato, Nobutaka, Ono, Yuichi, Suzuki, Atsushi, Fukamizu, Seiji, Nagata, Yasutoshi, Yamauchi, Yasuteru, Tada, Hiroshi, Hachiya, Hitoshi, Inaba, Osamu, Takahashi, Atsushi, Goya, Masahiko, Sasano, Tetsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105877/
https://www.ncbi.nlm.nih.gov/pubmed/36892146
http://dx.doi.org/10.1093/europace/euad056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105877/
https://www.ncbi.nlm.nih.gov/pubmed/36892146
http://dx.doi.org/10.1093/europace/euad056

Ejemplares similares